87 related articles for article (PubMed ID: 9740351)
1. Early expression of interleukin-12, p40 subunit and IFN-gamma inhibits regression of AK-5 tumor.
Nandakumar KS; Kumari AL; Khar A
Cytokines Cell Mol Ther; 1997 Dec; 3(4):225-32. PubMed ID: 9740351
[TBL] [Abstract][Full Text] [Related]
2. AK-5 tumor-induced modulation of host immune function: upregulation of Th-1-type cytokine response mediates early tumor regression.
Khar A; Kausalya S; Kamal MA
Cytokines Mol Ther; 1996 Mar; 2(1):39-46. PubMed ID: 9384688
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of antitumor immunity by IL-12 gene-transfected AK-5 tumor cells in vivo.
Nandakumar KS; Lakshmi Rao K; Pardhasaradhi BV; Khar A
Cytokines Cell Mol Ther; 1999 Mar; 5(1):7-14. PubMed ID: 10390075
[TBL] [Abstract][Full Text] [Related]
4. Role of cytokines in the maintenance of the memory immune response induced by a rat histiocytoma in syngeneic hosts.
Nandakumar KS; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1998 Sep; 4(3):169-75. PubMed ID: 9825842
[TBL] [Abstract][Full Text] [Related]
5. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
6. AK-5 tumor-induced expression of interleukin-12: role of IL-12 in NK-mediated AK-5 regression.
Hegde SP; Bright JJ; Kausalya S; Khar A
Cell Immunol; 1995 May; 162(2):241-7. PubMed ID: 7743551
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activation-associated induction of target cell DNA fragmentation in a spontaneously regressing rat histiocytoma.
Bright JJ; Kausalya S; Khar A
Immunology; 1995 Aug; 85(4):638-44. PubMed ID: 7558160
[TBL] [Abstract][Full Text] [Related]
8. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.
Rakhit A; Yeon MM; Ferrante J; Fettner S; Nadeau R; Motzer R; Bukowski R; Carvajal DM; Wilkinson VL; Presky DH; Magram J; Gately MK
Clin Pharmacol Ther; 1999 Jun; 65(6):615-29. PubMed ID: 10391667
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune response.
Jyothi MD; Khar A
Cancer Immunol Immunother; 2000 Dec; 49(10):563-72. PubMed ID: 11129327
[TBL] [Abstract][Full Text] [Related]
11. Correlation of in vitro and in vivo effects of interferon-gamma with the spontaneous regression of a rat histiocytoma.
Kausalya S; Varalakshmi C; Khar A
J Interferon Cytokine Res; 1995 Jul; 15(7):647-54. PubMed ID: 7553237
[TBL] [Abstract][Full Text] [Related]
12. [Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice].
Pan YL; Zheng S; Xiao ZX; Cao J; Yao HP
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):51-4. PubMed ID: 12757646
[TBL] [Abstract][Full Text] [Related]
13. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
15. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression.
Liu TF; Jones BM; Wong RW; Srivastava G
Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated intragraft gene expression, ICAM-1 and IL-2R molecules, and apoptotic epithelial cells during rejection of rat small intestine allografts.
Li Y; Li N; Li Y; Wu B; Li J
Chin Med J (Engl); 2001 Oct; 114(10):1089-94. PubMed ID: 11677773
[TBL] [Abstract][Full Text] [Related]
17. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
19. Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking.
Bhaumik S; Mitra R; Varalakshmi C; Khar A
Exp Cell Res; 2001 May; 266(1):44-52. PubMed ID: 11339823
[TBL] [Abstract][Full Text] [Related]
20. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
